In the Democratic Republic of the Congo, Claude is helping teams respond to a rare and deadly strain of Ebola.
Unresolvable The public record could not settle it.
Factual: Statements about the present or the past, checked against the record: did they hold up?
The second judge would not resolve this claim; the verdict shown is the first judge's.
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
Judge as of 21 Oct 2026. True if credible evidence shows that, at or shortly before that date, organisations responding to an Ebola outbreak in the DRC (health ministry, WHO, NGOs, or partners) were using Claude in that response, and that the outbreak involved a rare or uncommon strain (for example a species other than Zaire ebolavirus, such as Bundibugyo or Sudan) that was deadly. Mostly true if Claude was used in the DRC Ebola response but the strain detail is slightly off (for example a common strain described as rare), or the use was by a single partner organisation. Mixed if Claude was used only in Ebola-related work outside the active field response (for example general research), or if there was no active outbreak at the time. Mostly false if Claude's use was only planned or piloted and not deployed. False if there is no Ebola outbreak response in the DRC involving Claude, as shown by responder or partner accounts that describe the tools used and leave Claude out.
Set before the research began.
Evidence (4)
-
E1 AI in healthcare: from fighting epidemics to family doctors Euronews · 15 October 2026
“Since May, teams on the ground in the Democratic Republic of Congo (DRC) have been fighting the Bundibugyo strain of the Ebola virus.”
-
E2 AI in healthcare: from fighting epidemics to family doctors Euronews · 15 October 2026
“To evaluate the answers and reports, Anthropic's Claude model was used. Among those involved in the study were CEPI, the WHO Regional Office for Africa and the national biomedical research institute INRB.”
-
E3 WHO Health Emergencies EPI-WIN webinar: Update on the current Ebola Bundibugyo virus disease outbreak World Health Organization · 1 November 2026
“As of 31 October 2026, a total of 10,467 confirmed cases and 5,103 deaths had been reported across 67 health zones in eight provinces, with the outbreak surpassing the 10,000-case mark.”
-
E4 The Situation Report Anthropic · 19 September 2026 Own record
“Since May, teams on the ground in the Democratic Republic of the Congo (DRC) have been combating a rare strain of Ebolavirus called Bundibugyo (BDBV).”
Reasoning
The evidence shows an active Bundibugyo Ebola outbreak in the DRC (E1, E3, E4) and that Claude was used to evaluate answers and reports in a study involving CEPI, the WHO Regional Office for Africa and INRB (E2). It does not show whether that use was part of the active field response or separate research, and the criteria treat those cases differently.
Cite this claim
Daniela Amodei, “In the Democratic Republic of the Congo, Claude is helping teams respond to a rare and deadly strain of Ebola.” (said 21 October 2026). Verdict: unresolvable. Reliability API, claim c_bfa7bbf8e1c8, method 0.1.0+28da144b, dataset release v1.1.2. https://epistacklabs.com/claims/c_bfa7bbf8e1c8
This claim is in dataset release v1.1.2, with the same verdict.
Reply to this claim
More factual claims by Daniela Amodei
-
Mostly true
“In the lab, Claude designed new protein binders from scratch.”
In laboratory work, Anthropic's Claude designed new protein binders from scratch.
-
Mostly true
“including open-source code much of the internet runs on, before attackers could exploit them.”
-
Resolved true
“They also showed that more than 6,000 women had come in for prenatal care, but only 1,762 had delivered with a healthcare worker present, a discrepancy that the team is investigating and addressing.”
-
Resolved true
“Those dashboards flagged a spike of 25,000 pneumonia cases, so the team can anticipate and plan for future surges.”
-
Resolved true
“Sometimes Claude is wrong.”
Verdicts are made automatically; how verdicts are made.